Norazo Hijimi: Delaying monetary policy adjustments may bring inflation risks and harm the economy
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Regenerative medicine device company RegenLab USA (RGNA.US) sets IPO price at $6–$8 per share, aiming to raise $18 million
RegenLab USA announced its IPO terms on Tuesday.
Surging global demand drives increased production, US natural gas giants expect record high output this year
With global demand surging, U.S. energy companies are expected to reach a record high in natural gas production by 2026.
TPG (TPG.US) reportedly in talks to acquire UK data center Ark, valued at around 5 billions USD
According to sources familiar with the matter, TPG is in talks with Elliott Investment Management to acquire the UK data center company Ark at a valuation of approximately $5 billion.

Nomura (NMR.US) reports a 27% year-on-year increase in net profit for the first half of the fiscal year, with wealth management net inflows hitting a record high
Nomura Holdings (NMR.US) released its financial results for the second quarter of fiscal year 2026/27 (July–September), ending in September 2026: net revenue reached 607.5 billion yen (approximately $3.9 billion), an 18% year-on-year increase.
